SE8901593L - Laangtidsverkande diklofenak-natrium-preparat - Google Patents

Laangtidsverkande diklofenak-natrium-preparat

Info

Publication number: SE8901593L
Authority: SE; Sweden
Prior art keywords: diclofenac; diclofenac sodium; long; release; diclofenak
Prior art date: 1988-08-16

Application number

SE8901593A

Other languages

Unknown language ( )

English (en)

Other versions

SE509029C2 (sv

SE8901593D0 (sv

Inventor

M Okada

Original Assignee

Ss Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-08-16

Filing date

1989-05-03

Publication date

1990-12-06

1989-05-03 Application filed by Ss Pharmaceutical Co filed Critical Ss Pharmaceutical Co

1989-05-03 Publication of SE8901593D0 publication Critical patent/SE8901593D0/sv

1990-12-06 Publication of SE8901593L publication Critical patent/SE8901593L/sv

1998-11-30 Publication of SE509029C2 publication Critical patent/SE509029C2/sv

Links

238000002360 preparation method Methods 0.000 title abstract 3
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 title 1
230000007774 longterm Effects 0.000 title 1
229910052708 sodium Inorganic materials 0.000 title 1
239000011734 sodium Substances 0.000 title 1
229960001193 diclofenac sodium Drugs 0.000 abstract 4
JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical compound [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 abstract 4
239000008280 blood Substances 0.000 abstract 2
210000004369 blood Anatomy 0.000 abstract 2
229960001259 diclofenac Drugs 0.000 abstract 2
DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 abstract 2
238000013268 sustained release Methods 0.000 abstract 2
239000012730 sustained-release form Substances 0.000 abstract 2
239000011248 coating agent Substances 0.000 abstract 1
238000000576 coating method Methods 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
150000007524 organic acids Chemical class 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

SE8901593A 1988-08-16 1989-05-03 Långtidsverkande diklofenak-natriumpreparat SE509029C2 (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP20349888		1988-08-16

Publications (3)

Publication Number	Publication Date
SE8901593D0 SE8901593D0 (sv)	1989-05-03
SE8901593L true SE8901593L (sv)	1990-12-06
SE509029C2 SE509029C2 (sv)	1998-11-30

Family

ID=16475153

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE8901593A SE509029C2 (sv)	1988-08-16	1989-05-03	Långtidsverkande diklofenak-natriumpreparat

Country Status (13)

Country	Link
US (1)	US4968505A (sv)
JP (1)	JPH07116028B2 (sv)
KR (1)	KR950003610B1 (sv)
BE (1)	BE1002710A5 (sv)
CA (1)	CA1319616C (sv)
CH (1)	CH678813A5 (sv)
DE (1)	DE3915150C2 (sv)
FR (1)	FR2635460B1 (sv)
GB (1)	GB2221842B (sv)
HK (1)	HK48194A (sv)
IT (1)	IT1231517B (sv)
NL (1)	NL194882C (sv)
SE (1)	SE509029C2 (sv)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2514078B2 (ja) *	1988-08-22	1996-07-10	エスエス製薬株式会社	圧縮成型製剤
US5079001A (en) *	1989-11-03	1992-01-07	Ciba-Geigy Corporation	Liquid oral formulation of diclofenac
US5015481A (en) *	1990-05-03	1991-05-14	G. D. Searle & Co.	Stabilized pharmaceutical admixture composition
JPH04230625A (ja) *	1990-12-27	1992-08-19	Standard Chem & Pharmaceut Corp Ltd	噴霧乾燥したジクロフェナクナトリウムを含み腸溶性の被覆を有するマイクロカプセルからなる微分散した錠剤組成物の製造方法
EP0520119A1 (de) *	1991-06-17	1992-12-30	Spirig Ag Pharmazeutische Präparate	Neue orale Diclofenaczubereitung
US5518737A (en) *	1991-10-16	1996-05-21	Orion-Yhtyma Oy	Peroral drug delivery system
EP0653935B1 (en) *	1992-08-05	2002-05-08	F.H. FAULDING & CO. LIMITED	Pelletised pharmaceutical composition
JP3349535B2 (ja) *	1993-01-12	2002-11-25	フロイント産業株式会社	球形顆粒の製造方法
DE4403943A1 (de)	1994-02-08	1995-08-10	Hexal Pharma Gmbh	Orale Azrneimittelzubereitung mit Diclofenac-Natrium
US5837284A (en)	1995-12-04	1998-11-17	Mehta; Atul M.	Delivery of multiple doses of medications
US5922736A (en) *	1995-12-04	1999-07-13	Celegene Corporation	Chronic, bolus administration of D-threo methylphenidate
US6486177B2 (en) *	1995-12-04	2002-11-26	Celgene Corporation	Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
EP1690531A3 (en) *	1996-09-30	2010-01-20	Alza Corporation	Dosage form and method for administering drug
CA2264852C (en) *	1996-09-30	2005-11-01	Alza Corporation	Use of methylphenidate or a pharmaceutically acceptable salt thereof
US6919373B1 (en)	1996-11-12	2005-07-19	Alza Corporation	Methods and devices for providing prolonged drug therapy
ES2129010B1 (es) *	1997-01-02	2000-01-16	Gold Oscar	Composicion de accion prolongada en granulos que contienen 4-nitro-2- fenoximetansulfonanilida y su procedimiento de preparacion.
ES2129356B1 (es) *	1997-03-26	2000-01-16	Pierre Fabre Iberica S A	Forma farmaceutica de liberacion prolongada y procedimiento para su o btencion.
US6312724B1 (en)	1997-04-04	2001-11-06	Isa Odidi	Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof
US6962997B1 (en) *	1997-05-22	2005-11-08	Celgene Corporation	Process and intermediates for resolving piperidyl acetamide steroisomers
CN100444843C (zh) *	1998-08-10	2008-12-24	旭化成制药株式会社	法舒地尔盐酸盐缓释口服制剂
AU2001291738A1 (en) *	2000-08-10	2002-02-18	Unihart Corporation	"Slow release" pharmaceutical compositions comprising lithium carbonate
FR2842735B1 (fr) *	2002-07-26	2006-01-06	Flamel Tech Sa	Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
US20050239830A1 (en) *	2004-04-26	2005-10-27	Vikram Khetani	Methods of diminishing co-abuse potential
US20060127421A1 (en) *	2004-12-09	2006-06-15	Celgene Corporation	Treatment using D-threo methylphenidate
EP2719377B1 (en) *	2011-06-10	2018-04-18	Nipro Corporation	Method for producing orodispersible tablets
US8962020B2 (en) *	2012-07-26	2015-02-24	Glycadia Inc.	Long-acting and controlled release formulations of 2-[(3-chlorophenyl) amino] phenylacetic acid
WO2017084680A1 (en) *	2015-11-17	2017-05-26	Rontis Hellas S.A.	Pharmaceutical composition containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
CN114306260B (zh) *	2021-12-29	2023-10-24	濮阳市汇元药业有限公司	一种新型双氯芬酸钠片及其制备方法
DE202022100544U1 (de)	2022-01-31	2022-02-16	Ranjitsing Babasing Bayas	Neue orale Streifen- oder Dünnfilmform von Diclofenac-Natrium

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH647676A5 (fr) *	1978-12-22	1985-02-15	Donald E Panoz	Formes galeniques a usage oral, a liberation programmee et leurs procedes de preparation.
FR2470599A1 (fr) *	1979-12-07	1981-06-12	Panoz Donald	Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
CH655507B (sv) *	1983-01-12	1986-04-30
DE3328401A1 (de) *	1983-08-05	1985-02-21	Merckle GmbH, 7902 Blaubeuren	Injizierbare loesung zur behandlung von entzuendungen
IE56459B1 (en) *	1983-12-21	1991-08-14	Elan Corp Ltd	Controlled absorption pharmaceutical formulation
DE3446873A1 (de) *	1984-12-21	1986-07-10	Merckle Gmbh	Fluessige diclofenac-zubereitungen
CH664085A5 (de) *	1985-02-08	1988-02-15	Ciba Geigy Ag	Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
JPS61280426A (ja) *	1985-06-04	1986-12-11	Ikeda Mohandou:Kk	消炎鎮痛用貼付剤
US5188840A (en) *	1985-09-26	1993-02-23	Chugai Seiyaku Kabushiki Kaisha	Slow-release pharmaceutical agent
IE63321B1 (en) *	1986-02-03	1995-04-05	Elan Corp Plc	Drug delivery system
US4814183A (en) *	1987-08-31	1989-03-21	Merck & Co., Inc.	Device for the controlled release of drugs with Donnan-like modulation by charged insoluble resins
CH675537A5 (sv) *	1988-03-25	1990-10-15	Ciba Geigy Ag

1989
- 1989-05-03 SE SE8901593A patent/SE509029C2/sv not_active IP Right Cessation
- 1989-05-04 GB GB8910271A patent/GB2221842B/en not_active Expired - Lifetime
- 1989-05-04 CA CA000598715A patent/CA1319616C/en not_active Expired - Fee Related
- 1989-05-08 JP JP1114461A patent/JPH07116028B2/ja not_active Expired - Fee Related
- 1989-05-09 DE DE3915150A patent/DE3915150C2/de not_active Expired - Fee Related
- 1989-05-10 KR KR1019890006268A patent/KR950003610B1/ko not_active Expired - Fee Related
- 1989-05-12 NL NL8901200A patent/NL194882C/nl not_active IP Right Cessation
- 1989-05-17 US US07/353,016 patent/US4968505A/en not_active Expired - Lifetime
- 1989-05-31 FR FR898907203A patent/FR2635460B1/fr not_active Expired - Fee Related
- 1989-06-01 IT IT8948030A patent/IT1231517B/it active
- 1989-06-22 BE BE8900683A patent/BE1002710A5/fr not_active IP Right Cessation
- 1989-06-27 CH CH2389/89A patent/CH678813A5/de not_active IP Right Cessation
1994
- 1994-05-19 HK HK48194A patent/HK48194A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
FR2635460A1 (fr)	1990-02-23
FR2635460B1 (fr)	1994-09-16
DE3915150A1 (de)	1990-03-01
NL194882B (nl)	2003-02-03
CH678813A5 (sv)	1991-11-15
HK48194A (en)	1994-05-27
BE1002710A5 (fr)	1991-05-14
JPH02237918A (ja)	1990-09-20
US4968505A (en)	1990-11-06
SE509029C2 (sv)	1998-11-30
KR950003610B1 (ko)	1995-04-17
IT1231517B (it)	1991-12-07
GB2221842B (en)	1991-10-16
GB2221842A (en)	1990-02-21
GB8910271D0 (en)	1989-06-21
JPH07116028B2 (ja)	1995-12-13
NL194882C (nl)	2003-06-04
DE3915150C2 (de)	1997-04-17
SE8901593D0 (sv)	1989-05-03
IT8948030A0 (it)	1989-06-01
NL8901200A (nl)	1990-03-16
KR900002769A (ko)	1990-03-23
CA1319616C (en)	1993-06-29

Legal Events

Date	Code	Title	Description
2004-02-03	NUG	Patent has lapsed

Publication	Publication Date	Title
SE8901593D0 (sv)	1989-05-03	Laangtidsverkande diklofenak-natrium-preparat
LV12399A (lv)	1999-12-20	Uzlabotas vienreiz diena lietojamas pulsejosas miniciklina mogades sistemas
EA200000468A1 (ru)	2000-12-25	Терапевтическая композиция для введения толтеродина с контролируемым высвобождением
FI96273B (sv)	1996-02-29	Förfarande för framställning av läkemedels kontrollerat frigörande dosform
CZ277718B6 (en)	1993-03-17	Transdermal therapeutic system
DK0436370T3 (da)	1993-10-11	Farmaceutisk præparat til kontrolleret afgivelse og fremgangsmåde til fremstilling deraf
DE3866390D1 (de)	1992-01-09	Pharmazeutische zubereitungen von acrivastine.
YU49495B (sh)	2006-08-17	Formulacije oksikodona sa kontrolisanim otpuštanjem i njihova upotreba
DK293087D0 (da)	1987-06-09	Fast dihydrocodeinpraeparat med reguleret afgivelse
ATE163849T1 (de)	1998-03-15	Arzneimittel enthaltend als wirkstoff r-alpha- liponsäure oder s-alpha-liponsäure
DE3686936D1 (de)	1992-11-12	Am zielorgan wirkendes enterales abgabesystem.
GB2196848B (en)	1990-11-14	Controlled release hydromorphone composition
DE69022876D1 (de)	1995-11-16	Arzneimittelformulierungen mit verzögerter Wirkstoffabgabe.
LU91037I2 (fr)	2003-10-22	Somatulina autogel
ATE75604T1 (de)	1992-05-15	Antiphlogistika enthaltende pharmazeutische formulierungen mit gesteuerter freigabe.
EE04218B1 (et)	2004-02-16	Toimeainena klodronaati ja ekstsipiendina ränistatud mikrokristallilist tselluloosi sisaldav farmatseutiline preparaat ning farmatseutilise preparaadi tootmismeetod
DE69008107D1 (de)	1994-05-19	Zubereitung mit verzögerter Freigabe eines Hydrochlorids eines basischen Arzneistoffs.
EP0019403A3 (en)	1981-10-07	Hydroxyalkyl-starch drug carrier and method of administering a biologically active compound to an animal
IL92799A0 (en)	1990-09-17	Benzimidazole derivatives with gastric acid inhibition and process for its preparation
FI900470A0 (fi)	1990-01-30	Aktivaemnen kontrollerat avgivande system och foerfarande foer dess framstaellning.
US4931440A (en)	1990-06-05	Uricosuric composition
DE3675277D1 (de)	1990-12-06	Catechinamide, verfahren zu ihrer herstellung, zwischenprodukte und pharmazeutische zubereitung.
Krechniak et al.	1991	Effect of selected pyrethroids on cholinesterase activity in rat.
AR002736A1 (es)	1998-04-29	Uso de ester 3-metil-5-etilico de acido 2,6-dimetil-4-(2,3-diclorofenil-1,4 -dihidropiridin-3,5-dicarboxilico (felodipina) para fabricar un medicamento ypreparacion farmaceutica para el tratamiento de la disfuncion cerebral.
KR940008688A (ko)	1994-05-16	필수지방산에 의해 킬레이트화된 아연정제